CLINICAL_TRIALS
other
· 2011-02-02
Clinical Trial Update: Pioglitazone Incretin Study [Phase 4]
Summary
Phase 4 study of pioglitazone in an incretin therapy context in Type 2 diabetes mellitus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Vermont | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED